Interplay between brain stem angiotensins and monocyte chemoattractant protein-1 as a novel mechanism for pressor response after ischemic stroke

Neurobiology of Disease

Volumn 71, Issue , 2014, Pages 292-304

  Chang, Alice Y W ^a,b,c,d   Li, Faith C H ^a   Huang, Chi Wei ^a,d   Wu, Julie C C ^a   Dai, Kuang Yu ^a   Chen, Chang Han ^a   Li, Shau Hsuan ^a   Su, Chia Hao ^a   Wu, Re Wen ^a  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^b NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^c KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^d NATIONAL SUN YAT SEN UNIVERSITY   (Taiwan)

Author keywords

Aliskiren; Angiotensin isoforms and receptors; Ischemic stroke; Middle cerebral artery occlusion; Monocyte chemoattractant protein 1; Neuroinflammation; Pressor response after stroke; Rostral ventrolateral medulla

Indexed keywords

ANGIOTENSIN DERIVATIVE; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; NERVE PROTEIN;

ANALYSIS OF VARIANCE; ANIMAL; BLOOD PRESSURE; BRAIN ISCHEMIA; BRAIN STEM; COMPLICATION; DISEASE MODEL; GENE EXPRESSION REGULATION; GENETICS; HEART RATE; MALE; METABOLISM; NEUROLOGIC EXAMINATION; PATHOLOGY; PHYSIOLOGY; RAT; SPRAGUE DAWLEY RAT; STROKE;

ANALYSIS OF VARIANCE; ANGIOTENSINS; ANIMALS; BLOOD PRESSURE; BRAIN ISCHEMIA; BRAIN STEM; CHEMOKINE CCL2; DISEASE MODELS, ANIMAL; GENE EXPRESSION REGULATION; HEART RATE; MALE; NERVE TISSUE PROTEINS; NEUROLOGIC EXAMINATION; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER; STROKE;

EID: 84908174202     PISSN: 09699961     EISSN: 1095953X     Source Type: Journal    
DOI: 10.1016/j.nbd.2014.08.005     Document Type: Article

References (51)

1. Ally A., Nauli S.M., Maher T.J. Cardiovascular responses and neurotransmission in the ventrolateral medulla during skeletal muscle contraction following transient middle cerebral artery occlusion and reperfusion. Brain Res. 2002, 952:176-187.
2. Aoki S., Ohtsuki T., Hosomi N., Sueda Y., Kono T., Yamawaki T., Matsumoto M. Blood pressure variability and prognosis in acute ischemic stroke with vascular compression on the rostral ventrolateral medulla (RVLM). Hypertens. Res. 2011, 34:617-622.
3. Arakelyan A., Petrkova J., Hermanova Z., Boyajyan A., Lukl J., Petrek M. Serum levels of the MCP-1 chemokine in patients with ischemic stroke and myocardial infarction. Mediat. Inflamm. 2005, 2005:175-179.
4. Bae E.H., Kim I.J., Joo S.Y., Kim E.Y., Choi J.S., Kim C.S., Ma S.K., Lee J., Kim S.W. Renoprotective effects of the direct renin inhibitor aliskiren on gentamicin-induced nephrotoxicity in rats. J. Renin Angiotensin Aldosterone Syst. 2013, 10.1177/1470320312474853.
5. Buraczynska K., Luchowski P., Wojczal J., Ksiazek A., Stelmasiak Z. Monocyte chemoattractant protein (MCP-1) A-2518G gene polymorphism in stroke patients with different comorbidities. Clin. Biochem. 2010, 43:1421-1426.
6. Chan J.Y.H., Wang L.L., Ou C.C., Chan S.H.H. Downregulation of angiotensin subtype 1 receptor in rostral ventrolateral medulla during endotoxemia. Hypertension 2003, 42:103-109.
7. Chan S.H.H., Wang L.L., Tseng H.L., Chan J.Y.H. Upregulation of AT1 receptor gene on activation of protein kinase Cbeta/nicotinamide adenine dinucleotide diphosphate oxidase/ERK1/2/c-fos signaling cascade mediates long-term pressor effect of angiotensin II in rostral ventrolateral medulla. J. Hypertens. 2007, 25:1845-1861.
8. Chan S.H.H., Wu C.W., Chang A.Y.W., Hsu K.S., Chan J.Y.H. Transcriptional upregulation of brain-derived neurotrophic factor in rostral ventrolateral medulla by angiotensin II: significance in superoxide homeostasis and neural regulation of arterial pressure. Circ. Res. 2010, 107:1127-1139.
9. Dong Y.F., Kataoka K., Toyama K., Sueta D., Koibuchi N., Yamamoto E., Yata K., Tomimoto H., Ogawa H., Kim-Mitsuyama S. Attenuation of brain damage and cognitive impairment by direct renin inhibition in mice with chronic cerebral hypoperfusion. Hypertension 2011, 58:635-642.
10. Donnan G.A., Fisher M., Macleod M., Davis S.M. Stroke. Lancet 2008, 371:1612-1623.
11. Du D., Chen J., Liu M., Zhu M., Jing H., Fang J., Shen L., Zhu D., Yu J., Wang J. The effects of angiotensin II and angiotensin-(1-7) in the rostral ventrolateral medulla of rats on stress-induced hypertension. PLoS One 2013, 8:e70976.
12. Faure S., Chapot R., Tallet D., Javellaud J., Achard J.M., Oudart N. Cerebroprotective effect of angiotensin IV in experimental ischemic stroke in the rat mediated by AT(4) receptors. J. Physiol. Pharmacol. 2006, 57:329-342.
13. Geeganage C., Tracy M., England T., Sare G., Moulin T., Woimant F., Christensen H., De Deyn P.P., Leys D., O'Neill D., Ringelstein E.B., Bath P.M. Relationship between baseline blood pressure parameters (including mean pressure, pulse pressure, and variability) and early outcome after stroke: data from the Tinzaparin in Acute Ischaemic Stroke Trial (TAIST). Stroke 2011, 42:491-493.
14. Huang B.S., White R.A., Bi L., Leenen F.H. Central infusion of aliskiren prevents sympathetic hyperactivity and hypertension in Dahl salt-sensitive rats on high salt intake. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2012, 302:R825-R832.
15. Iadecola C., Alexander M. Cerebral ischemia and inflammation. Curr. Opin. Neurol. 2001, 14:89-94.
16. Jiang L., Newman M., Saporta S., Chen N., Sanberg C., Sanberg P.R., Willing A.E. MIP-1alpha and MCP-1 induce migration of human umbilical cord blood cells in models of stroke. Curr. Neurovasc. Res. 2008, 5:118-124.
17. Jiang T., Gao L., Guo J., Lu J., Wang Y., Zhang Y. Suppressing inflammation by inhibiting the NF-κB pathway contributes to the neuroprotective effect of angiotensin-(1-7) in rats with permanent cerebral ischaemia. Br. J. Pharmacol. 2012, 167:1520-1532.
18. Ko Y.J., Lee J.S., Park B.C., Shin H.M., Kim J.A. Inhibitory effects of Zoagumhwan water extract and berberine on angiotensin II-induced monocyte chemoattractant protein (MCP)-1 expression and monocyte adhesion to endothelial cells. Vasc. Pharmacol. 2007, 47:189-196.
19. Kobayashi T., Kawamata T., Shibata N., Okada Y., Kobayashi M., Hori T. Angiotensin II type 1 receptor blocker telmisartan reduces cerebral infarct volume and peri-infarct cytosolic phospholipase A(2) level in experimental stroke. J. Neurotrauma 2009, 26:2355-2364.
20. Lattanzi S., Silvestrini M., Provinciali L. Elevated blood pressure in the acute phase of stroke and the role of angiotensin receptor blockers. Int. J. Hypertens. 2013, 2013:e941783.
21. Lee M., Saver J.L., Hong K.S., Hao Q., Chow J., Ovbiagele B. Renin-angiotensin system modulators modestly reduce vascular risk in persons with prior stroke. Stroke 2012, 43:113-119.
22. Losy J., Zaremba J. Monocyte chemoattractant protein-1 is increased in the cerebrospinal fluid of patients with ischemic stroke. Stroke 2001, 32:2695-2696.
23. Lüders S. Drug therapy for the secondary prevention of stroke in hypertensive patients: current issues and options. Drugs 2007, 67:955-963.
24. Luoh S.H., Chan S.H.H. Inhibition of baroreflex by angiotensin II via Fos expression in nucleus tractus solitarii of the rat. Hypertension 2001, 38:130-135.
25. Makówka A., Olejniczak-Fortak M., Nowicki M. A comparison of the antihypertensive and anti-inflammatory effects of aliskiren and ramipril add-on therapy in peritoneal dialysis patients-a pilot open label study. Kidney Blood Press. Res. 2012, 36:18-25.
26. Marks L., Carswell H.V., Peters E.E., Graham D.I., Patterson J., Dominiczak A.F., Macrae I.M. Characterization of the microglial response to cerebral ischemia in the stroke-prone spontaneously hypertensive rat. Hypertension 2001, 38:116-122.
27. McKinley M.J., Albiston A.L., Allen A.M., Mathai M.L., May C.N., McAllen R.M., Oldfield B.J., Mendelsohn F.A., Chai S.Y. The brain renin-angiotensin system: location and physiological roles. Int. J. Biochem. Cell Biol. 2003, 35:901-918.
28. Mecca A.P., Regenhardt R.W., O'Connor T.E., Joseph J.P., Raizada M.K., Katovich M.J., Sumners C. Cerebroprotection by angiotensin-(1-7) in endothelin-1-induced ischaemic stroke. Exp. Physiol. 2011, 96:1084-1096.
29. Min L.J., Mogi M., Tsukuda K., Jing F., Ohshima K., Nakaoka H., Kan-No H., Wang X.L., Chisaka T., Bai H.Y., Iwanami J., Horiuchi M. Direct stimulation of angiotensin II type 2 receptor initiated after stroke ameliorates ischemic brain damage. Am. J. Hypertens. 2014, 10.1093/ajh/hpu015.
30. Mogi M., Li J.M., Iwanami J., Min L.J., Tsukuda K., Iwai M., Horiuchi M. Angiotensin II type-2 receptor stimulation prevents neural damage by transcriptional activation of methyl methanesulfonate sensitive 2. Hypertension 2006, 48:141-148.
31. Nagai M., Terao S., Vital S.A., Rodrigues S.F., Yilmaz G., Granger D.N. Role of blood cell-associated angiotensin II type 1 receptors in the cerebral microvascular response to ischemic stroke during angiotensin-induced hypertension. Exp. Transl. Stroke Med. 2011, 3:15-23.
32. O'Brien E., Barton J., Nussberger J., Mulcahy D., Jensen C., Dicker P., Stanton A. Aliskiren reduces blood pressure and suppresses plasma renin activity in combination with a thiazide diuretic, an angiotensin-converting enzyme inhibitor, or an angiotensin receptor blocker. Hypertension 2007, 49:276-284.
33. Omura T., Yoshiyama M., Kim S., Matsumoto R., Nakamura Y., Izumi Y., Ichijo H., Sudo T., Akioka K., Iwao H., Takeuchi K., Yoshikawa J. Involvement of apoptosis signal-regulating kinase-1 on Ang II-induced monocyte chemoattractant protein-1 expression. Arterioscler. Thromb. Vasc. Biol. 2004, 24:270-275.
34. Pan Q., Yang X.H., Cheng Y.X. Angiotensin II stimulates MCP-1 production in rat glomerular endothelial cells via NAD(P)H oxidase-dependent nuclear factor-kappa B signaling. Braz. J. Med. Biol. Res. 2009, 42:531-536.
35. Potter J., Robinson T., Ford G., James M., Jenkins D., Mistri A., Bulpitt C., Drummond A., Jagger C., Knight J., Markus H., Beevers G., Dewey M., Lees K., Moore A., Paul S. CHHIPS (Controlling Hypertension and Hypotension Immediately Post-Stroke) Pilot Trial: rationale and design. J. Hypertens. 2005, 23:649-655.
36. Regenhardt R.W., Desland F., Mecca A.P., Pioquinto D.J., Afzal A., Mocco J., Sumners C. Anti-inflammatory effects of angiotensin-(1-7) in ischemic stroke. Neuropharmacology 2013, 71:154-163.
37. Rhoney D.H., Moser L.R. Angiotensin receptor blockers following acute stroke. Expert. Rev. Cardiovasc. Ther. 2011, 9:691-696.
38. Rusai K., Schmaderer C., Hermans J.J., Lutz J., Heemann U., Baumann M. Direct renin inhibition in a rat model of chronic allograft injury. Transplantation 2011, 92:999-1004.
39. Saad M.A., Abbas A.M., Boshra V., Elkhateeb M., El Aal I.A. Effect of angiotensin II type 1 receptor blocker, candesartan, and beta 1 adrenoceptor blocker, atenolol, on brain damage in ischemic stroke. Acta Physiol. Hung. 2010, 97:159-171.
40. Sandset E.C., Bath P.M., Boysen G., Jatuzis D., Kõrv J., Lüders S., Murray G.D., Richter P.S., Roine R.O., Terént A., Thijs V., Berge E. The angiotensin-receptor blocker candesartan for treatment of acute stroke (SCAST): a randomised, placebo-controlled, double-blind trial. Lancet 2011, 377:741-750.
41. Sardo M.A., Campo S., Mandraffino G., Saitta C., Bonaiuto A., Castaldo M., Cinquegrani M., Pizzimenti G., Saitta A. Tissue factor and monocyte chemoattractant protein-1 expression in hypertensive individuals with normal or increased carotid intima-media wall thickness. Clin. Chem. 2008, 54:814-823.
42. Sawhney J.P. First orally active DRI aliskiren-a new prospect in management of hypertension and beyond. Indian Heart J. 2010, 62:49-56.
43. Schilling M., Strecker J.K., Schäbitz W.R., Ringelstein E.B., Kiefer R. Effects of monocyte chemoattractant protein 1 on blood-borne cell recruitment after transient focal cerebral ischemia in mice. Neuroscience 2009, 161:806-812.
44. Schmerbach K., Pfab T., Zhao Y., Culman J., Mueller S., Villringer A., Muller D.N., Hocher B., Unger T., Thoene-Reineke C. Effects of aliskiren on stroke in rats expressing human renin and angiotensinogen genes. PLoS One 2010, 5:e15052.
45. Schroten N.F., Gaillard C.A., van Veldhuisen D.J., Szymanski M.K., Hillege H.L., de Boer R.A. New roles for renin and prorenin in heart failure and cardiorenal crosstalk. Heart Fail. Rev. 2012, 17:191-201.
46. Singh Y., Singh K., Sharma P.L. Effect of combination of renin inhibitor and Mas-receptor agonist in DOCA-salt-induced hypertension in rats. Mol. Cell. Biochem. 2013, 373:189-194.
47. Spyer K.M. Annual review prize lecture. Central nervous mechanisms contributing to cardiovascular control. J. Physiol. 1994, 474:1-19.
48. Sykora M., Diedler J., Poli S., Rupp A., Turcani P., Steiner T. Blood pressure course in acute stroke relates to baroreflex dysfunction. Cerebrovasc. Dis. 2010, 30:172-179.
49. 1 receptor blockade. Biochem. Biophys. Res. Commun. 2011, 409:275-279.
50. Wu Y.P., Ling E.A. Induction of Fos-like immunoreactivity in the hypothalamic, medullary and thoracic spinal cord neurons following middle cerebral artery occlusion in rats. Neurosci. Res. 1998, 30:145-153.
51. Zhang J., Peng Y., Fan H., Chen M., Xu T., Zhang Y. Blood pressure and early clinical outcome among acute ischemic stroke patients. Can. J. Neurol. Sci. 2011, 38:225-229.